Artivila Therapeutics
Shenzhen
About Artivila Therapeutics
Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform, providing first-in-class new molecules consistently and efficiently. Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $38.6M
- Funding stage: Seed
- Last round: Seed (Mar 2022)
- Website: artivila.com
- Phone: +86-0755-237799972
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/artivila-therapeutics-32937 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.